Back  |   PharmaSentry Homepage

  • Article Summary
  • Alternate drugs not always identical [Pittsburgh Post-Gazette]
    From Pittsburgh Post-Gazette (PA) 25-Jun-2010
    June 25--The seizures are less frequent for Melissa Linz since her radical brain surgery in December, when 3 inches of gray mater were removed from her skull. But the Shaler woman is convinced she might not have needed that surgery in the first place if her anti-seizure medication hadn't been changed by her health insurance company.

    Key Concepts
    apos
    medications
    patients
    health insurance
    prescriptions
    Linz
    seizures
    drugs
    brand-name
    medicines
    substitutes
    consumers
    physicians
    absorption
    protocols
    Summary
    June 25--The seizures are less frequent for Melissa Linz since her radical brain surgery in December, when 3 inches of gray mater were removed from her skull.
    But the Shaler woman is convinced she might not have needed that surgery in the first place if her anti-seizure medication hadn't been changed by her health insurance company.
    She, along with millions of other patients and policyholders each year, found herself the unwilling casualty of prescription switching -- a doctor prescribes one medicine, but the government or a health insurer wants you to use another, usually a generic brand, because it's cheaper.
    And usually, that's a good idea.
    Using the cheaper medicine tempers the growth of pharmaceutical expenses across the system, saving American consumers tens of millions of dollars a year.
    It's why most health plans, both private and government-run, have "preferred" drug lists and specific formularies detailing what drugs will be covered by which policies under which circumstances.
    And it's why the Drug Price Competition and Patent Term Restoration Act was approved by Congress in 1984 to make generics more widely available to U.S. consumers.
    Often, the generic substitute is chemically indistinguishable from the prescribed brand-name drug.